Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03414983
Title An Investigational Immunotherapy Study of Nivolumab With Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Colorectal Cancer That Has Spread (CheckMate 9X8)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

colorectal cancer

Therapies

Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin

Bevacizumab + Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin

Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.